Literature DB >> 16303065

Self-sampling versus physician-sampling for human papillomavirus testing.

T Agorastos1, K Dinas, B Lloveras, R Font, J R Kornegay, J Bontis, S de Sanjose.   

Abstract

We evaluated the detection of human papillomavirus (HPV) infection using two sampling methods of cervical exfoliated cells, consisting of self-sampling of vaginal cells and cervical sampling performed by the physician. Women included were 379 patients of the general population attending outpatient clinics in Northern Greece for routine cytological cervical dysplasia screening. HPV DNA detection was similar with both sampling techniques. The HPV prevalences in self-collected samples were 4.7% and 3.7% in the physician-collected samples (P>0.05). The Kappa statistic for HPV DNA agreement between the two methods was 0.54 (95% Confidence interval = 0.33-0.75). Self-sampling of cervico-vaginal exfoliated cells could be used as an alternative option to test for HPV infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16303065     DOI: 10.1258/095646205774763225

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  6 in total

1.  Accuracy and cost-effectiveness of cervical cancer screening by high-risk human papillomavirus DNA testing of self-collected vaginal samples.

Authors:  Akhila Balasubramanian; Shalini L Kulasingam; Atar Baer; James P Hughes; Evan R Myers; Constance Mao; Nancy B Kiviat; Laura A Koutsky
Journal:  J Low Genit Tract Dis       Date:  2010-07       Impact factor: 1.925

2.  A Viable and Simple Self-Sampling Method for Human Papillomavirus Detection among South African Adolescents.

Authors:  David H Adler; Fatima Laher; Erica Lazarus; Katherine Grzesik; Glenda E Gray; Bruce Allan; Anna-Lise Williamson
Journal:  J Immunol Tech Infect Dis       Date:  2013-09-18

3.  Human papillomavirus infection in women in Puerto Rico: agreement between physician-collected and self-collected anogenital specimens.

Authors:  Ana Patricia Ortiz; Josefina Romaguera; Cynthia M Pérez; Yomayra Otero; Marievelisse Soto-Salgado; Keimari Méndez; Yari Valle; Maria Da Costa; Erick Suarez; Joel Palefsky; Guillermo Tortolero-Luna
Journal:  J Low Genit Tract Dis       Date:  2013-04       Impact factor: 1.925

4.  Comparison of natural histories of human papillomavirus detected by clinician- and self-sampling.

Authors:  Anna-Barbara Moscicki; Lea Widdice; Yifei Ma; Sepideh Farhat; Susanna Miller-Benningfield; Janet Jonte; Julie Jay; Cheryl Godwin de Medina; Evelyn Hanson; Lisa Clayton; Stephen Shiboski
Journal:  Int J Cancer       Date:  2010-10-15       Impact factor: 7.396

5.  Cost-effectiveness analysis of human papillomavirus DNA testing and Pap smear for cervical cancer screening in a publicly financed health-care system.

Authors:  I H-I Chow; C-H Tang; S-L You; C-H Liao; T-Y Chu; C-J Chen; C-A Chen; R-F Pwu
Journal:  Br J Cancer       Date:  2010-11-23       Impact factor: 7.640

6.  Vaccination against human papillomavirus among 865 female students from the health professions in central Greece: a questionnaire-based cross-sectional study.

Authors:  Dimitrios Papagiannis; George Rachiotis; Emmanouil K Symvoulakis; Alexandros Daponte; Ioanna N Grivea; George A Syrogiannopoulos; Christos Hadjichristodoulou
Journal:  J Multidiscip Healthc       Date:  2013-11-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.